Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

Mutations in the adenomatous polyposis coli or beta-catenin gene lead to cytosolic accumulation of beta-catenin and, subsequently, to increased transcriptional activity of the beta-catenin-T cell-factor/lymphoid-enhancer-factor complex. This process seems to play an essential role in the development of most colorectal carcinomas. To identify genes activated by beta-catenin overexpression, we used colorectal cell lines for transfection with the beta-catenin gene and searched for genes differentially expressed in the transfectants. There are four genes affected by beta-catenin overexpression; three overexpressed genes code for two components of the AP-1 transcription complex, c-jun and fra-1, and for the urokinase-type plasminogen activator receptor (uPAR), whose transcription is activated by AP-1. The direct interaction of the beta-catenin-T cell-factor/lymphoid-enhancer-factor complex with the promoter region of c-jun and fra-1 was shown in a gel shift assay. The concomitant increase in beta-catenin expression and the amount of uPAR was confirmed in primary colon carcinomas and their liver metastases at both the mRNA and the protein levels. High expression of beta-catenin in transfectants, as well as in additionally analyzed colorectal cell lines, was associated with decreased expression of ZO-1, which is involved in epithelial polarization. Thus, accumulation of beta-catenin indirectly affects the expression of uPAR in vitro and in vivo. Together with the other alterations, beta-catenin accumulation may contribute to the development and progression of colon carcinoma both by dedifferentiation and through proteolytic activity.

[1]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[2]  A. Copeta,et al.  Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. , 1998, Cancer research.

[3]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[4]  G. Viglietto,et al.  Neoplastic transformation of rat thyroid cells requires the junB and fra‐1 gene induction which is dependent on the HMGI‐C gene product , 1997, The EMBO journal.

[5]  J. Skibber,et al.  Transcriptional activation of the urokinase receptor gene in invasive colon cancer , 1994, International journal of cancer.

[6]  A. García de Herreros,et al.  Phorbol ester-induced scattering of HT-29 human intestinal cancer cells is associated with down-modulation of E-cadherin. , 1993, Journal of cell science.

[7]  E. Wieschaus,et al.  A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Moyer,et al.  Development and characterization of normal colonic epithelial cell lines derived from normal mucosa of patients with colon cancer. , 1994, American journal of surgery.

[9]  S. L. Gonias,et al.  Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility* , 1998, The Journal of Biological Chemistry.

[10]  D. Cines,et al.  Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. , 1993, Cancer research.

[11]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[12]  M. Itoh,et al.  Submembranous junctional plaque proteins include potential tumor suppressor molecules , 1993, The Journal of cell biology.

[13]  B. Gumbiner,et al.  Antagonism of Cell Adhesion by an α-Catenin Mutant, and of the Wnt-signaling Pathway by α-Catenin in Xenopus Embryos , 1997, The Journal of cell biology.

[14]  Y. Doki,et al.  Expression of occludin, tight-junction-associated protein, in human digestive tract. , 1997, The American journal of pathology.

[15]  K. Danø,et al.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. , 1991, The Journal of biological chemistry.

[16]  P. Polakis,et al.  The APC Protein and E-cadherin Form Similar but Independent Complexes with α-Catenin, β-Catenin, and Plakoglobin (*) , 1995, The Journal of Biological Chemistry.

[17]  L. Lund,et al.  The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. , 1994, The Journal of investigative dermatology.

[18]  M. Takeichi,et al.  Cell binding function of E‐cadherin is regulated by the cytoplasmic domain. , 1988, The EMBO journal.

[19]  F. Molemans,et al.  Genomic organization of the human beta-catenin gene (CTNNB1). , 1996, Genomics.

[20]  W. Bodmer.  The Somatic Evolution of Cancer , 1997, Journal of the Royal College of Physicians of London.

[21]  W. Birchmeier,et al.  E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton , 1994, The Journal of cell biology.

[22]  B. Gumbiner,et al.  Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus , 1996, The Journal of cell biology.

[23]  Ken W. Y. Cho,et al.  The Xenopus homeobox gene twin mediates Wnt induction of goosecoid in establishment of Spemann's organizer. , 1997, Development.

[24]  J. Papkoff,et al.  Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin , 1994, The Journal of cell biology.

[25]  A. Rajasekaran,et al.  Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions , 1996, The Journal of cell biology.

[26]  A. Deisseroth,et al.  Interaction of nuclear proteins with an AP‐1/CRE‐like promoter sequence in the human TNF‐α gene , 1994 .

[27]  G. Berx,et al.  Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells. , 1995, Cancer research.

[28]  D. Boyd,et al.  Requirement of an Upstream AP-1 Motif for the Constitutive and Phorbol Ester-inducible Expression of the Urokinase-type Plasminogen Activator Receptor Gene* , 1996, The Journal of Biological Chemistry.

[29]  H. Steinbeisser,et al.  Cortical rotation is required for the correct spatial expression of nr3, sia and gsc in Xenopus embryos. , 1997, The International journal of developmental biology.

[30]  W. Nelson,et al.  Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[32]  Bert Vogelstein,et al.  Gatekeepers and caretakers , 1997, Nature.

[33]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[34]  G. D'aiuto,et al.  Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. , 1994, Cancer research.

[35]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[36]  Rudolf Grosschedl,et al.  The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures , 1992, Cell.

[37]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Allshire.  Introduction of large linear minichromosomes into Schizosaccharomyces pombe by an improved transformation procedure. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Dale,et al.  Signal transduction by the Wnt family of ligands. , 1998, The Biochemical journal.

[40]  C. V. Van Itallie,et al.  ZO-1 mRNA and protein expression during tight junction assembly in Caco- 2 cells , 1989, The Journal of cell biology.

[41]  M. Waterman,et al.  Induction of a β-catenin-LEF-1 complex by wnt-1 and transforming mutants of β-catenin , 1997, Oncogene.

[42]  F. Masiarz,et al.  Association of the APC gene product with beta-catenin. , 1993, Science.

[43]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[44]  D. Kimelman,et al.  Activation of Siamois by the Wnt pathway. , 1996, Developmental biology.

[45]  A. Levinson,et al.  Prevention of metastasis by inhibition of the urokinase receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W F Bodmer,et al.  Beta-catenin mutations in cell lines established from human colorectal cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. Birchmeier,et al.  Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. , 1995, Oncogene.

[48]  P. Cohen,et al.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.

[49]  H. Clevers,et al.  Ectopic activation of lymphoid high mobility group‐box transcription factor TCF‐1 and overexpression in colorectal cancer cells , 1997, International journal of cancer.

[50]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[51]  Mark Peifer,et al.  β-Catenin as Oncogene--The Smoking Gun , 1997, Science.